Tabatabai, A., Höfmann, S., Zhou, T., Theiss, F., Kranz, M., Fluemann, R., Möllmann, M., Hartnack, M., Kesper, S., Arora, A., Klein, S., Knittel, G., Reinhardt, H. C. (2025). IRF2BP2 mutations activate IL-1β-mediated NF-κB signaling and confer actionable anti-IL-1β sensitivity in DLBCL. Blood. https://doi.org/10.1182/blood-2025-3528